[Retracted] Meta-Analysis of the Effect of Glucocorticoids on Adult Acute Respiratory Distress Syndrome

Table 1

Clinical characteristics of the included studies.

Author	Year	Study design	Sample size (hormone group/control group)	The age of the hormone group, years	The age of the control group, years	Hormone group dosing regimen	Treatment time, days
Annane et al. [11]	2006	RCT	85/95	62.0 ± 15.0	58.0 ± 18.0	Hydrocortisone, 50 mg/6h	25
Azevedo et al. [12]	2011	RCT	133/133	57.6 ± 5.2	56.2 ± 4.9	Methylprednisolone, 1 g/d	3
Bernard et al. [13]	1987	RCT	50/49	55.0 ± 2.0	56.0 ± 2.0	Methylprednisolone, 120 mg/d	1
Confalonierid et al. [14]	2005	RCT	23/23	66.6 ± 14.7	60.4 ± 17.3	Hydrocortisone, 240 mg/d	7
Meduri et al. [16]	1998	RCT	16/8	47.0 ± 3.9	51.0 ± 6.6	Methylprednisolone, 2 mg/kg/d	32
Meduri et al. [15]	2007	RCT	63/28	50.1 ± 15.3	53.2 ± 15.3	Methylprednisolone, 1 mg/kg/d	28
Steinberg et al. [17]	2006	RCT	89/91	49.0 ± 19.0	49.2 ± 16.5	Methylprednisolone, 2 mg/kg/d	25
Tongyoo et al. [18]	2016	RCT	98/99	64.5 ± 17.3	64.3 ± 16.0	Hydrocortisone, 50 mg/6h	7
Villar et al. [19]	2020	RCT	139/138	56.0 ± 14.0	58.0 ± 15.0	Dexamethasone, 20 mg/d	10
Wan et al. [20]	2011	RCT	38/43	51.0 ± 15.0	49.0 ± 13.0	Dexamethasone, 1 mg/kg/d	3